Duloxetine improves joint pain associated with aromatase inhibitor treatment for early-stage breast cancer
eMediNexus, 12 February 2018
remove_red_eye 705 Views
#Obstetrics and Gynecology #Oncology #Orthopedics #Radiology
remove_red_eye 705 Views
#Obstetrics and Gynecology #Oncology #Orthopedics #Radiology
According to a study reported online in the Journal of Clinical Oncology, treatment with duloxetine for aromatase inhibitor-associated musculoskeletal symptoms of joint pain, joint stiffness, functioning was superior to placebo among postmenopausal women with early-stage breast cancer.
To continue reading this article
Continue reading your article with a Emedinexus account..
Free Membership!
